Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Taurochenodeoxycholic acid

Taurochenodeoxycholic acid

Taurochenodeoxycholic acid structure

Taurochenodeoxycholic acid 

structure
  • CAS No:

    516-35-8

  • Formula:

    C26H45NO6S

  • Chemical Name:

    Taurochenodeoxycholic acid

  • Synonyms:

    Ethanesulfonic acid,2-[[(3α,5β,7α)-3,7-dihydroxy-24-oxocholan-24-yl]amino]-;Taurochenodeoxycholic acid;Taurine,N-(3α,7α-dihydroxy-5β-cholan-24-oyl)-;Cholane,ethanesulfonic acid deriv.;2-[[(3α,5β,7α)-3,7-Dihydroxy-24-oxocholan-24-yl]amino]ethanesulfonic acid;12-Deoxycholyltaurine;12-Desoxycholyltaurine;Chenodeoxycholyltaurine;Taurochenodesoxycholic acid;3α,7α-Dihydroxy-N-(2-sulfoethyl)-5β-cholan-24-amide;Chenyltaurine

  • Categories:

    Biochemical Engineering  >  Plant Extracts

Description

Taurochenodeoxycholic acid is one of the main bioactive substances of animals' bile acid.


Solid


Taurochenodeoxycholic acid is a bile acid taurine conjugate of chenodeoxycholic acid. It has a role as a mouse metabolite and a human metabolite. It derives from a chenodeoxycholic acid. It is a conjugate acid of a taurochenodeoxycholate.|Taurochenodeoxycholic acid is an experimental drug that is normally produced in the liver. Its physiologic function is to emulsify lipids such as cholesterol in the bile. As a medication, taurochenodeoxycholic acid reduces cholesterol formation in the liver, and is likely used as a choleretic to increase the volume of bile secretion from the liver and as a cholagogue to increase bile discharge into the duodenum. It is also being investigated for its role in inflammation and cancer therapy.|A bile salt formed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt. It acts as detergent to solubilize fats in the small intestine and is itself absorbed. It is used as a cholagogue and choleretic.

Taurochenodeoxycholic acid Basic Attributes

499.7

499.70

651KU15938

Characteristics

132

4.86900

Solid

1.2±0.1 g/cm3

1.552

207.4 Ų [M+Na]+ [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|205.39 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|221.75 Ų [M-H]- [CCS Type: DT, Method: stepped-field]|207.2 Ų [M-H]- [CCS Type: DT, Method: single field calibrated]|218.7 Ų [M+H-2H2O]+ [CCS Type: DT, Method: single field calibrated]

Drug Information

Taurochenodeoxycholic acid is likely indicated as a choleretic and cholagogue. It is also being investigated for its role in inflammation and cancer therapy.

Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). (See all compounds classified as Cholagogues and Choleretics.)|Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)

Chenodeoxycholic acid is a primary bile acid in the liver that combines with taurine to form the bile acid taurochenodeoxycholic acid. In the bile, taurochenodeoxycholic acid is either a sodium (most) or potassium salt. Taurochenodeoxycholic acid is normally produced in the liver, and its physiologic function as a bile salt is to emulsify lipids such as cholesterol in the bile. As a medication, taurochenodeoxycholic acid reduces cholesterol formation in the liver, and is likely used as a choleretic to increase the volume of bile secretion from the liver and as a cholagogue to increase bile discharge into the duodenum. The mechanism of action of taurochenodeoxycholic acid in inflammation and cancer has yet to be determined.

Acid, Taurochenodeoxycholic

Taurochenodeoxycholic acid Use and Manufacturing

Methods of Manufacturing

Under room temperature, will be of ursodesoxycholic acid 10.0g (25.4mmol) and P-nitro phenol 3.54g (25.4mmol) by adding 100 ml methylene chloride, stirring cooling to 10-20°C. Dropwise N, N '-dicyclohexyl carbodiimide 5.25g (25.4mmol) dichloromethane solution, completion of the dropping, 20-45 °C reaction 2 hours, filtering, for removing insoluble matter, the filtrate concentrated to obtain yellowish oily 12.59g, yield 96.3percent.The above-mentioned oil to b the nitrile is heavy crystallization, to obtain white adhesive material, directly used for the next step reaction.Under room temperature, the taurine potassium 18-crown -6 complexes 15.73g (36.8mmol) and such oils by adding dichloromethane in sheet, stirring. Reaction at room temperature 5 hours later, TLC (ethyl acetate: petroleum ether = 1:1) monitoring, the reaction is complete. Adding 0.21g glacial acetic acid, stirring a large amount of solid precipitated, filtering to obtain the white solid, the above-mentioned white solid by adding 20 ml in water, stirring crystallization. Filtering and drying to obtain solid 11.56g, total yield 84.7percent (purity 99.8percent, HPLC), deoxycholic acid niu Huange not be detected, the largest unknown shan Za 0.04percent.Under room temperature, will be of ursodesoxycholic acid 10.0g (25.4mmol) and phenol 2.39g (25.4mmol) by adding 100 ml methylene chloride, stirring cooling to 10-20°C. Dropwise N, N '-dicyclohexyl carbodiimide 5.25g (25.4mmol) dichloromethane solution, completion of the dropping, 5-20 °C reaction 2 hours, filtering, for removing insoluble matter, the filtrate concentrated to obtain yellowish oily 11.45g, yield 96.0percent.The above-mentioned oil to b the nitrile is heavy crystallization, to obtain white adhesive material, directly used for the next step reaction.Under room temperature, the taurine potassium 18-crown -6 complexes 15.68g (36.7mmol) and such oils by adding dichloromethane in sheet, stirring. Reaction at room temperature 5 hours later, TLC (ethyl acetate: petroleum ether = 1:1) monitoring, the reaction is complete. Adding 0.19g glacial acetic acid, stirring a large amount of solid precipitated, filtering to obtain the white solid, the above-mentioned white solid by adding 20 ml in water, stirring crystallization. Filtering and drying to obtain solid 11.63g, the overall yield is 85.2percent (purity 99.7percent, HPLC), deoxycholic acid niu Huange not be detected, the largest unknown shan Za 0.04percent.

Uses

Taurochenodeoxycholic Acid is a bile acid conjugate and metabolite Taurolithocholic Acid (T009100) with antiinflammatory activity. Taurochenodeoxycholic Acid has been shown to inhibit hepatocyte apoptosis through suppression of Bid translocation to mitochondria.

Lipids -> Sterol Lipids [ST] -> Steroid conjugates [ST05] -> Taurine conjugates [ST0504]

Computed Properties

Molecular Weight:499.7
XLogP3:3.6
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:7
Exact Mass:499.29675933
Monoisotopic Mass:499.29675933
Topological Polar Surface Area:132
Heavy Atom Count:34
Complexity:858
Defined Atom Stereocenter Count:10
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Taurochenodeoxycholic acid

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.